# Evaluate — Vendor Intelligence Profile
> Source: Vedex (https://vedex.ai) | Generated: 2026-10-05T09:36:37.405Z

## Overview

- **Vendor Type**: data_provider
- **Headquarters**: London, United Kingdom
- **Year Founded**: 1996
- **Employee Count**: 350
- **Description**: Evaluate is a leading provider of commercial intelligence and predictive analytics for the pharmaceutical and biotech industries, offering comprehensive data on drug pipelines, clinical trials, and market forecasts to support strategic decision-making.
- **Slogan**: The gold standard for life science market intelligence.
- **Domain**: evaluate.com
- **Company Website**: https://evaluate.com

## Categories & Sectors

- **Categories**: Pharmaceutical Data, Biotech Market Intelligence, Clinical Trial Data, Drug Pipeline Analytics, Financial Forecasting
- **Sectors**: Pharmaceuticals, Biotechnology

## Marketplace Presence

- **Delivery Methods**: REST API, SFTP, Web UI download, Email
- **Geographic Coverage**: Global

## Intelligence Scores

- **Vendor Score**: 38.2
- **Market Presence**: 11.7
- **Trust & Compliance**: 49
- **Integration**: 29.3
- **AI Readiness**: 22
- **Business Maturity**: 58.7
- **Support & Operations**: 60.8

## Trust & Compliance (vendor-reported)

> These are the vendor's own attestations as collected from public sources, not Vedex's. Verify directly with the vendor.

- **Trust Score**: 57/100 (based on vendor-reported attestations, not verified by vedex)
- **SOC 2 Type II**: In progress
- **ISO 27001 Certified**: No
- **GDPR Compliance**: Fully compliant (DPA available)
- **Encryption Standards**: AES-256 at rest and TLS 1.2+ in transit
- **Penetration Testing**: Annual third-party penetration testing
- **Historical Breach Record**: No public incident found in our search (unverified)
- **Data Residency Options**: US, EU
- **Written Compliance Policies**: Data privacy, Information security, Intellectual property

## AI & ML Readiness

- **LLM-Friendly Output Formats**: Structured JSON with schemas
- **File Formats Supported**: CSV, JSON, Excel, XML

## Business & Funding

- **Funding Stage**: Acquired
- **Estimated ARR Range**: $50-100M
- **Key Customers**: Pfizer, Novartis, Roche, JPMorgan Chase, Goldman Sachs
- **Key Partnerships**: Clarivate, IQVIA

## Links

- Vedex Profile: https://vedex.ai/vendor/evaluate-40ba20
- Due Diligence: https://vedex.ai/due-diligence/evaluate-40ba20